Michael Morin

Michael Morin

Presidente presso
NCI Experimental Therapeutics Program
71 anni
Health Technology
Consumer Services
Miscellaneous

Profilo

Michael J.
Morin
is currently the Chairman of the Drug Discovery Initiative at the Children's Tumor Foundation and Co-Chairman at the NCI Experimental Therapeutics Program.
He previously worked as the Chief Executive Officer at Supportive Therapeutics, Vice President of Global Research & Development at Pfizer Inc., Chief Scientific Officer at Immunome, Inc., and Chief Scientific Officer at Onkaido Therapeutics LLC.
Morin holds a doctorate degree from the State University of New York at Buffalo and an undergraduate degree from the University of Lowell.

Posizioni attive di Michael Morin

SocietàPosizioneInizio
NCI Experimental Therapeutics Program
Presidente -
Corporate Officer/Principal -

Precedenti posizioni note di Michael Morin

SocietàPosizioneFine
Direttore Tecnico/Scientifico/R&S 01/09/2015
Amministratore Delegato 01/12/2014
PFIZER INC. Direttore Tecnico/Scientifico/R&S -
IMMUNOME, INC. Amministratore Delegato 01/05/2019
Vedi nel dettaglio l'esperienza di Michael Morin

Formazione di Michael Morin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

3

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private8

Health Technology

Health Technology

Consumer Services

Consumer Services

Miscellaneous

Health Technology

Health Technology

NCI Experimental Therapeutics Program

  1. Mercati
  2. Insiders
  3. Michael Morin